Fig. 1From: Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label studya Source of patients participating in this clinical trial. de novo = patients who did not participate in the lead-in study and had no prior AOM 400 exposure; Rollover-AOM 400 Arm = rollover patients from the lead-in study who had been randomized to the AOM 400 arm; Rollover-Placebo Arm = rollover patients from the lead-in study who had been randomized to the placebo arm. b Patient disposition across the study. Patients entered the oral aripiprazole cross-titration phase if they were not already receiving oral aripiprazole in their treatment regimen at screening. Those already on aripiprazole therapy at screening entered directly into the oral aripiprazole stabilization phase. AOM 400 aripiprazole once-monthly 400 mgBack to article page